Detalles de la búsqueda
1.
Pembrolizumab in Asian patients with microsatellite-instability-high/mismatch-repair-deficient colorectal cancer.
Cancer Sci
; 114(3): 1026-1036, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36369901
2.
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.
N Engl J Med
; 383(23): 2207-2218, 2020 12 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33264544
3.
Pembrolizumab versus chemotherapy for microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer (KEYNOTE-177): final analysis of a randomised, open-label, phase 3 study.
Lancet Oncol
; 23(5): 659-670, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35427471
4.
Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
Lancet Oncol
; 22(5): 665-677, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33812497
5.
Cetuximab plus irinotecan administered biweekly with reduced infusion time to heavily pretreated patients with metastatic colorectal cancer and related RAS and BRAF mutation status.
Int J Cancer
; 148(10): 2542-2556, 2021 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33336394
6.
ABCG2 Protein Levels and Association to Response to First-Line Irinotecan-Based Therapy for Patients with Metastatic Colorectal Cancer.
Int J Mol Sci
; 21(14)2020 Jul 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32708825
7.
Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer.
Br J Cancer
; 118(10): 1322-1328, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29695770
8.
Associations between primary tumor RAS, BRAF and PIK3CA mutation status and metastatic site in patients with chemo-resistant metastatic colorectal cancer.
Acta Oncol
; 57(8): 1057-1062, 2018 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-29380640
9.
Topoisomerase I copy number alterations as biomarker for irinotecan efficacy in metastatic colorectal cancer.
BMC Cancer
; 17(1): 48, 2017 01 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28077117
10.
Risk factors for brain metastases in patients with metastatic colorectal cancer.
Acta Oncol
; 56(5): 639-645, 2017 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-28447565
11.
Early 18F-FDG-PET/CT as a predictive marker for treatment response and survival in patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
Acta Oncol
; 55(9-10): 1175-1182, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-27548393
12.
FCGR polymorphisms and cetuximab efficacy in chemorefractory metastatic colorectal cancer: an international consortium study.
Gut
; 64(6): 921-8, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25011934
13.
MicroRNA Expression in Formalin-fixed Paraffin-embedded Cancer Tissue: Identifying Reference MicroRNAs and Variability.
BMC Cancer
; 15: 1024, 2015 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-26714641
14.
Improved survival with early adjuvant chemotherapy after colonic resection for stage III colonic cancer: A nationwide study.
J Surg Oncol
; 112(5): 538-43, 2015 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-26271357
15.
Capecitabine and bevacizumab in heavily pre-treated patients with advanced colorectal cancer.
Acta Oncol
; 51(2): 231-3, 2012 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-21936753
16.
Observer variability in a phase II trial - assessing consistency in RECIST application.
Acta Oncol
; 51(6): 774-80, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22432439
17.
A Randomized Placebo-Controlled Phase 2 Study of Gemcitabine and Capecitabine with or without T-ChOS as Adjuvant Therapy in Patients with Resected Pancreatic Cancer (CHIPAC).
Pharmaceutics
; 14(3)2022 Feb 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35335885
18.
Pre- and Perioperative Inflammatory Biomarkers in Older Patients Resected for Localized Colorectal Cancer: Associations with Complications and Prognosis.
Cancers (Basel)
; 14(1)2021 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35008324
19.
Addition of sunitinib to cetuximab and irinotecan in patients with heavily pre-treated advanced colorectal cancer.
Acta Oncol
; 49(6): 833-6, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20615171
20.
An open label phase 1 study evaluation safety, tolerability, and maximum tolerated dose of oral administration of irinotecan in combination with capecitabine.
Cancer Chemother Pharmacol
; 84(2): 441-446, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30949758